CBD Company Isodiol Purchases Assets; New Facility Development Begins

The well-known cannabidiol (CBD) company Isodiol (ISOL) had major company developments on April 17th.

The company announced a strategic purchase of three assets. The first purchase is of BSPG Laboratories that does CBD refining in the UK, the second is a Brazilian supplier of Purodiol to Brazilian patients, and finally three CBD processing patents from Hankang Biotech in China.

BSPG Laboratories Limited cost Isodiol the most out of the three purchases, the business will receive $13 million USD in total with a $25 million USD bonus agreement if the company can get government approval. BSPG will need Active Pharmaceutical Ingredient (API) approval from their government. This will allow the company to sell worldwide and be used clinically or for pharmaceutical use.

The last two purchases will only cost Isodiol $5.5 million. The Brazilian company Purodiol Do Brasil Ltda will be the second largest cost at $2 million in cash and $3 million in common stock. The three processing patents from Hankang Biotech Co., Ltd. will cost $500,000 USD.

Isodiol also announced a new CBD processing facility will be developed in Yunnan, China. This facility will have state-of-the-art processing capability with an estimated ability to process over 15 metric-tons (33,069lbs) of hemp for extraction daily. The new facility is expected to be the highest yield facility in the world and is expected to be completed by Q1 of 2019.

The stock value for ISOL did increase when this news was first released; however the stock has lost the 16.67% gain.

CBD Company Isodiol Purchases Assets; New Facility Development Begins

Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In

CBD Company Isodiol Purchases Assets; New Facility Development Begins